Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Novartis Ag (NVSEF) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Novartis Ag (NVSEF) over the last 17 years, with Q4 2025 value amounting to $7.2 million.

  • Novartis Ag's Shares Outstanding (Weighted Average) rose 2179.05% to $7.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $7.2 million, marking a year-over-year increase of 2179.05%. This contributed to the annual value of $7.2 million for FY2025, which is 2179.05% up from last year.
  • Novartis Ag's Shares Outstanding (Weighted Average) amounted to $7.2 million in Q4 2025, which was up 2179.05% from $1947000.0 billion recorded in Q3 2025.
  • Over the past 5 years, Novartis Ag's Shares Outstanding (Weighted Average) peaked at $2252000.0 billion during Q1 2021, and registered a low of $1.0 million during Q1 2023.
  • In the last 5 years, Novartis Ag's Shares Outstanding (Weighted Average) had a median value of $4.3 million in 2023 and averaged $755600.0 billion.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first skyrocketed by 12672316374180.79% in 2021, then crashed by 10000.0% in 2023.
  • Novartis Ag's Shares Outstanding (Weighted Average) (Quarter) stood at $2243000.0 billion in 2021, then plummeted by 100.0% to $2.8 million in 2022, then soared by 49.1% to $4.1 million in 2023, then skyrocketed by 43.34% to $5.9 million in 2024, then grew by 21.79% to $7.2 million in 2025.
  • Its last three reported values are $7.2 million in Q4 2025, $1947000.0 billion for Q3 2025, and $1958000.0 billion during Q2 2025.